Osteoimmunology: interactions of the immune and skeletal systems.
about
Osteoimmunology: Major and Costimulatory Pathway Expression Associated with Chronic Inflammatory Induced Bone LossAltered bone remodeling in psoriatic arthritisActeoside suppresses RANKL-mediated osteoclastogenesis by inhibiting c-Fos induction and NF-κB pathway and attenuating ROS productionTranscriptional regulation of bone and joint remodeling by NFATThe emerging field of osteoimmunologyIn silico analysis of autoimmune diseases and genetic relationships to vaccination against infectious diseases.Secretion of a truncated osteopetrosis-associated transmembrane protein 1 (OSTM1) mutant inhibits osteoclastogenesis through down-regulation of the B lymphocyte-induced maturation protein 1 (BLIMP1)-nuclear factor of activated T cells c1 (NFATc1) axTLR2-dependent modulation of osteoclastogenesis by Porphyromonas gingivalis through differential induction of NFATc1 and NF-kappaB.Gene expression profiling in monocytes and SNP association suggest the importance of the STAT1 gene for osteoporosis in both Chinese and Caucasians.Bone Loss Triggered by the Cytokine Network in Inflammatory Autoimmune Diseases.In vivo impact of a 4 bp deletion mutation in the DLX3 gene on bone development.NRROS Negatively Regulates Osteoclast Differentiation by Inhibiting RANKL-Mediated NF-N:B and Reactive Oxygen Species Pathways.Calycosin Suppresses RANKL-Mediated Osteoclastogenesis through Inhibition of MAPKs and NF-κB.TGF-beta1 on osteoimmunology and the bone component cellsAdvances in osteoclast biology reveal potential new drug targets and new roles for osteoclastsRANKL cytokine: from pioneer of the osteoimmunology era to cure for a rare diseaseContributions to osteoclast biology from Japan.Lentiviral small hairpin RNA knockdown of macrophage inflammatory protein-1γ ameliorates experimentally induced osteoarthritis in mice.The effects of rosiglitazone on osteoblastic differentiation, osteoclast formation and bone resorption.Corticosterone regulates the expression of neuropeptide Y and reelin in MLO-Y4 cells.Tumor-host cell interactions in the bone disease of myeloma.Osteoimmunology - Unleashing the concepts.Interaction of Tumor Necrosis Factor Receptor-associated Factor 6 (TRAF6) and Vav3 in the Receptor Activator of Nuclear Factor κB (RANK) Signaling Complex Enhances Osteoclastogenesis.The farnesoid X receptor negatively regulates osteoclastogenesis in bone remodeling and pathological bone loss.Beyond Antibodies: B Cells and the OPG/RANK-RANKL Pathway in Health, Non-HIV Disease and HIV-Induced Bone Loss.Platelet-rich plasma inhibits RANKL-induced osteoclast differentiation through activation of Wnt pathway during bone remodeling.Activated T lymphocytes suppress osteoclastogenesis by diverting early monocyte/macrophage progenitor lineage commitment towards dendritic cell differentiation through down-regulation of receptor activator of nuclear factor-kappaB and c-Fos.Rescue of a cherubism bone marrow stromal culture phenotype by reducing TGFβ signaling.Regulation of Osteoclast Differentiation by Cytokine Networks.Tectorigenin Promotes Osteoblast Differentiation and in vivo Bone Healing, but Suppresses Osteoclast Differentiation and in vivo Bone Resorption.Emerging and Established Models of Bone Metastasis.
P2860
Q27008993-EADCF67C-7FE5-4411-AD82-C494C25978B3Q28288855-4256C5B2-66D5-4A3F-B461-9052CEEAF9F2Q28535889-6EF3F30E-E813-4595-BCDF-51E56CC28725Q33998768-E9309133-3C23-49AB-947D-0BBFEA2411C5Q34108110-E69F6C32-8A8D-401F-B81A-03289F97A5FFQ34700616-5947AF6A-8822-4D66-86EB-DB855355317BQ34774474-6FE8CFF3-6E8D-4434-AACF-F93366FAF4E0Q35085107-8901ED33-36D5-49D1-A559-2520A4FD6E46Q35156259-AE180CE3-A4F3-46A3-AD1F-DF8D6799ECFAQ35614331-F8B6CB48-E50A-407B-92CE-7BE97B5284EBQ36197273-0249D275-3452-4C23-858B-62EDDFF2909EQ36221462-E6DCDEEF-16F1-4B09-8E2A-BC8D1AEE0FB4Q36404231-09C354AE-37C1-4FB5-B3E7-2FFFA3E3FC33Q36591727-B44DBF59-019A-46C4-AE9E-8641E7ABE935Q36733053-013CFC5F-231C-4CA8-A123-4B7D8CE686E9Q36898545-3E64D307-E8FF-4ABC-B98A-3916D92C68D2Q37038278-E94B5FFF-F1F4-4B7C-A6A8-90215F9D716CQ37208260-B24D5122-E301-401D-AB10-DE386BBFB0BDQ37461510-5A2DEDE0-1FFC-451F-B51B-E5E37FC382C2Q37461733-33956B98-BB4E-45D1-9CBA-147DD37DDCE1Q37771082-D4FC1DF8-C1F2-4A59-84E9-714E85BBA869Q37949580-2191F430-C688-4A95-A9B5-6AAFFABF3633Q38752770-1BA9DFA3-CBD0-410D-9B7D-F44100FD096AQ45006336-D91BD414-3F49-4D40-8962-2C502A664969Q47194100-64958C9A-A6DA-4CED-9C70-F7BA96ABB609Q47328685-93374D3A-5235-4E36-BC55-90B72BF9C906Q50925640-9306155E-4251-46EF-AF5F-37A9257C695EQ51741155-692F8FA6-7B1B-4E3B-9690-DE7A2BE50C72Q55226585-CC4D6A02-CFB9-4961-A247-7A04E415BDB5Q55467079-EA497869-C39C-49E4-AC3A-2CDF6112615CQ55515343-70C7D3BF-8F4E-441A-B656-B9632B7C441C
P2860
Osteoimmunology: interactions of the immune and skeletal systems.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Osteoimmunology: interactions of the immune and skeletal systems.
@ast
Osteoimmunology: interactions of the immune and skeletal systems.
@en
type
label
Osteoimmunology: interactions of the immune and skeletal systems.
@ast
Osteoimmunology: interactions of the immune and skeletal systems.
@en
prefLabel
Osteoimmunology: interactions of the immune and skeletal systems.
@ast
Osteoimmunology: interactions of the immune and skeletal systems.
@en
P2093
P1433
P1476
Osteoimmunology: interactions of the immune and skeletal systems.
@en
P2093
Jaerang Rho
Masamichi Takami
Yongwon Choi
P577
2004-02-01T00:00:00Z